Stephens Consulting’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$8.07K Hold
2,883
﹤0.01% 256
2025
Q3
$13.8K Hold
2,883
﹤0.01% 211
2025
Q2
$26.2K Sell
2,883
-45
-2% -$332 0.01% 245
2025
Q1
$26.4K Buy
2,928
+45
+2% +$475 0.01% 238
2024
Q4
$37.7K Hold
2,883
0.01% 208
2024
Q3
$45.2K Hold
2,883
0.01% 195
2024
Q2
$38.9K Hold
2,883
0.01% 204
2024
Q1
$79.9K Hold
2,883
0.02% 134
2023
Q4
$55.5K Hold
2,883
0.02% 168
2023
Q3
$46.6K Hold
2,883
0.02% 174
2023
Q2
$54.9K Hold
2,883
0.02% 154
2023
Q1
$41.9K Hold
2,883
0.03% 187
2022
Q4
$56.3K Hold
2,883
0.04% 162
2022
Q3
$69.5K Hold
2,883
0.06% 139
2022
Q2
$90.7K Hold
2,883
0.07% 110
2022
Q1
$127K Hold
2,883
0.1% 108
2021
Q4
$125K Buy
+2,883
New +$113K 0.1% 134

Other funds holding ACH

Stephens Consulting's ACH Position: Q4 2025 in Review

Stephens Consulting held its Accendra Health (ACH) position steady in Q4 2025 at 2,883 shares worth $8.07K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Stephens Consulting first reported a position in ACH in Q4 2021 and has held it in 17 quarters since. The position peaked at $127K in Q1 2022. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Stephens Consulting held 2,883 shares of Accendra Health worth $8.07K as of Q4 2025.
  • Stephens Consulting left its Accendra Health share count unchanged in Q4 2025.
  • Accendra Health made up ﹤0.01% of Stephens Consulting's portfolio in Q4 2025, its #256 holding.
  • Stephens Consulting first reported a position in Accendra Health in Q4 2021 and has held it in 17 quarters since.
  • Stephens Consulting's Accendra Health position peaked at $127K in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.